Anti-viral efficacy of a next-generation CD4-binding site bNAb in SHIV-infected animals in the absence of anti-drug antibody responses-Reference-Cited by-同舟云学术

Anti-viral efficacy of a next-generation CD4-binding site bNAb in SHIV-infected animals in the absence of anti-drug antibody responses

Published:2022-10 Issue:10 Volume:25 Page:105067
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Lovelace Sarah E.,Helmold Hait Sabrina,Yang Eun Sung,Fox Madison L.,Liu Cuiping,Choe Misook,Chen Xuejun,McCarthy Elizabeth,Todd John-Paul,Woodward Ruth A.,Koup Richard A.,Mascola John R.,Pegu Amarendra^ORCID

Funder

Vaccine Research Center

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference67 articles.

1. Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody;Asokan;Proc. Natl. Acad. Sci. USA,2020

2. Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals;Bar-On;Nat. Med.,2018

3. Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys;Barouch;Nature,2013

4. Advances in simian--human immunodeficiency viruses for nonhuman primate studies of HIV prevention and cure;Bauer;Curr. Opin. HIV AIDS,2020

5. Human immunodeficiency virus type 1 monoclonal antibodies suppress acute simian-human immunodeficiency virus viremia and limit seeding of cell-associated viral reservoirs;Bolton;J. Virol.,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Recombinant Adeno-Associated Virus for Passive Immunization and Protection against Infectious Diseases;Molecular Genetics, Microbiology and Virology;2024-03

2. Use of recombinant adeno-associated virus for passive immunization and protection against infectious diseases;Molecular Genetics Microbiology and Virology (Russian version);2024

3. Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections;Nature Communications;2023-06-22

4. Adeno-associated virus-vectored delivery of HIV biologics: the promise of a “single-shot” functional cure for HIV infection;Journal of Virus Eradication;2023-03